Novel targeted agents for the treatment of lung cancer in China
- PMID: 26331815
- DOI: 10.1002/cncr.29522
Novel targeted agents for the treatment of lung cancer in China
Abstract
Since the discovery of epidermal growth factor receptor mutations and epidermal growth factor receptor tyrosine kinase inhibitors, lung cancer treatment in China has entered the precision era. However, novel targeted agents based on novel biomarkers still need to be developed. In the current study, the authors review the biomarker features of lung cancer in the Chinese population and the novel agents that are aimed at novel targets. Furthermore, they discuss issues that require improvement for the production of novel drugs and provided future directions for development in China.
Keywords: China; lung cancer; novel agents; novel targets.
© 2015 American Cancer Society.
Comment in
-
Lung cancer in China: The new frontier?Cancer. 2015 Sep 1;121 Suppl 17:3058-60. doi: 10.1002/cncr.29569. Cancer. 2015. PMID: 26331811 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
